Clinical Trials on Multiple Myeloma, Refractory in New Zealand
Total 2650 results
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Faron Pharmaceuticals LtdRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Relapsed/Refractory AMLUnited States, Finland
-
Carevive Systems, Inc.RecruitingBreast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Acute Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterBeyondSpring Pharmaceuticals Inc.Active, not recruiting
-
Innate PharmaCompletedMultiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruiting
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedMultiple MyelomaUnited States
-
Tufts Medical CenterNational Cancer Institute (NCI)Not yet recruitingSmoldering Multiple MyelomaUnited States
-
AttenuonTerminated
-
PharmaMarTerminatedRelapsed/Refractory LeukemiaUnited States
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthAmgenSuspendedMultiple MyelomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Yale UniversityCompleted
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of RochesterTerminatedMultiple MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer Center; Hackensack Meridian HealthCompletedFatigue | Multiple MyelomaUnited States
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
ChimerixActive, not recruiting
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyAnorMEDTerminatedMultiple MyelomaUnited States
-
Lava TherapeuticsActive, not recruitingAcute Myeloid Leukemia | Multiple Myeloma | Chronic Lymphocytic LeukemiaUnited States, Spain, France, Netherlands
-
Celularity IncorporatedCompleted
-
Seagen Inc.Terminated
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Israel
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)WithdrawnRecurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
Sorrento Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; GlaxoSmithKline and other collaboratorsCompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada